Creative Bioscience
Latest round
- Series D
Last raised
- Oct 2021
Total raised
- $220M
Investors
- 18
About Creative Bioscience
Based in Guangzhou, China, and established in 2015, Creative Bioscience is a tumor early diagnosis product developer that focuses on intestinal cancer. It's business scope includes development, manufacturing and sales of in vitro diagnostic (IVD) products, and related technical services. It has four third-party medical testing laboratories in Guangzhou, Tianjin, Wuhan and Jinan. In 2020, it acquired Helixgen company, which strengthened its basic R&D ability and expand team. The company provides vitro diagnostic (IVD) products, and related technical services. Diagnostics products includes human gene polymorphism test kit, gene mutation test kit. Lab services includes molecular diagnostics services. biology reagents includes HelixGen MHC tetramer, HelixGen MHC tetramer customization service. The company plan to continue to develop early diagnosis products for high-incidence tumors, including lung cancer, bladder cancer, liver cancer, cervical cancer.
Who invested in Creative Bioscience
18 investors across 5 rounds
See all investors in Creative Bioscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Creative Bioscience
Who invested in Creative Bioscience?
Creative Bioscience has 18 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Creative Bioscience raised?
Creative Bioscience has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Creative Bioscience last raise money?
Creative Bioscience's most recent round on record is a Series D, in Oct 2021.
What does Creative Bioscience do?
Based in Guangzhou, China, and established in 2015, Creative Bioscience is a tumor early diagnosis product developer that focuses on intestinal cancer.
Where is Creative Bioscience headquartered?
Creative Bioscience is headquartered in Guangzhou, China.
Which VCs invest in companies like Creative Bioscience?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Creative Bioscience's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Creative Bioscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.